
Pierpaolo Maietta
Aversa hospital, ItalyTitle: Differentiation between myopericarditis and acute myocardial infarction on presentation in the emergency department using the admission C-reactive protein to troponin ratio
Abstract
Acute Myocarditis (am), a recent-onset
inflammation of the heart, has heterogeneous clinical presentations, varying
from minor symptoms to high-risk cardiac conditions with severe heart failure,
refractory arrhythmias, and cardiogenic shock. am is moving from being a
definitive diagnosis based on histological evidence of inflammatory infiltrates
on cardiac tissue to a working diagnosis supported by high sensitivity troponin
increase in association with specific cardiac magnetic resonance imaging (cmri)
findings. though experts still diverge between those advocating for
histological definition versus those supporting a mainly clinical definition of
myocarditis, in the real-world practice the diagnosis of am has undoubtedly
shifted from being mainly biopsy-based to solely cmri-based in most of clinical
scenarios. it is thus important to clearly define selected settings where emb
is a must, as information derived from histology is essential for an optimal
management. as in other medical conditions, a risk-based approach should be
promoted in order to identify the most severe am cases requiring appropriate
bundles of care, including early recognition, transfer to tertiary centers,
aggressive circulatory supports with inotropes and mechanical devices,
histologic confirmation and eventual immunosuppressive therapy. despite
improvements in recognition and treatment of am, including a broader use of
promising mechanical circulatory supports, severe forms of am are still
burdened by dismal outcomes. this review is focused on recent clinical studies
and registries that shed new insights on am. attention will be paid to
contemporary outcomes and predictors of prognosis, the emerging entity of
immune checkpoint inhibitors-associated myocarditis, updated cmri diagnostic
criteria, new data on the use of temporary mechanical circulatory supports in
fulminant myocarditis. the role of viruses as etiologic agents will be reviewed
and a brief update on pediatric am is also provided. finally, we summarize a
risk-based approach to am, based on available evidence and clinical experience.
Biography
Pierpaolo Maietta has completed his PhD at the age of 33 years from Second University of naples USA. He is the head of head of emergency department in aversa hospital. He has over 300 publications.